Healthnet Letter from Consulting Ortho
This was the conulting Orthopedic Surgeons recommendation letter that pushed Healthnet to finally approve my request for hip resurfacing surgery with Dr. Amstutz. Unfortunately, they sent the letter to me on December 1, the day I was in surgery with Dr. Bose in
Letter from Consulting Ortho:
At the current time, there has been approval for the femoral component of the proposed device (the Conserve hip is just the femoral side, the Conserve Plus has both sides). The femoral component has been approved and is in use for greater than 10 years.
It is not experimental, it is not investigational, and is approved by the FDA. Similarly, the use of a metal bearing surface on the acetabular side has been in use for several years, and is not experimental or investigational. It is FDA approved, both for Wright Medical (the manufacturer of the Conserve / Conserve-Plus), as well as several other orthopaedic device manufacturers.
There has been extensive work with the Conserve-Plus over the years, initially performed in
In conclusion, the proposed surgery has the advantages of providing for an alternative bearing surface for increased longevity, sacrificing less bone than a conventional total hip replacement, and providing added stability due to the size of the femoral component (which is favorable in this active patient who has at least some degree of hip dysplasia).
The Conserve Plus is a good option for young patients with hip disease. It is conservative in terms of bone removal, it uses an alternative bearing surface, and this device combines technology that has been FDA approved in separate parts, just the “whole” package is waiting final approval. The advantages are listed above, and the procedure should be approved.